SCPH — Scpharmaceuticals Share News
0.000.00%
Last trade - 00:00- $304.36m
- $314.75m
- $36.33m
Brief: Scpharmaceuticals Reports Qtrly Net Loss Per Share, Basic And Diluted $0.28
scPharmaceuticals Inc expected to post a loss of 31 cents a share - Earnings Preview
scPharmaceuticals Inc reports results for the quarter ended in December - Earnings Summary
Brief: scPharmaceuticals Inc Reports Fourth Quarter And Full Year 2021 Financial Results
scPharmaceuticals Inc expected to post a loss of 34 cents a share - Earnings Preview
Brief: scPharmaceuticals Inc Reports Third Quarter 2021 Financial Results And Provides Business Update
Brief: ScPharmaceuticals Presents Late-Breaking FREEDOM-HF Study Data At Heart Failure Society Of America Annual Scientific Meeting 2021
scPharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary
Brief: scPharmaceuticals Inc Reports Second Quarter 2021 Financial Results
scPharmaceuticals Inc expected to post a loss of 30 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-BriaCell, Velodyne Lidar, Qualigen, Compass Minerals
U.S. STOCKS ON THE MOVE-Glaukos, American Airlines, Allied Healthcare, Apple
scPharmaceuticals up after heart drug reduces treatment costs in study
Brief: Scpharmaceuticals Inc. Announces Positive Top-Line Results From Freedom-Hf Study
Brief: ScPharmaceuticals Inc Announces Receipt Of Written Minutes From Type C Meeting With FDA Regarding Development Of Furoscix
scPharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary
Brief: Scpharmaceuticals Inc Reports First Quarter 2021 Financial Results And Provides Business Update
Brief: scPharmaceuticals Inc Inc Files For Mixed Shelf Of Upto $150 Million - SEC Filing
Brief: Scpharmaceuticals Inc Says Furoscix New Drug Application Resubmission Anticipated In Q3 2021